86 related articles for article (PubMed ID: 8275032)
21. Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease.
Imoto S; Oomoto Y; Murata K; Das H; Murayama T; Kajimoto K; Sugimoto T; Gomyo H; Nakagawa T; Nishimura R; Koizumi T
Int J Hematol; 2000 Jul; 72(1):92-7. PubMed ID: 10979216
[TBL] [Abstract][Full Text] [Related]
22. An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation.
Schots R; Van Riet I; Othman TB; Trullemans F; De Waele M; Van Camp B; Kaufman L
Bone Marrow Transplant; 2002 Oct; 30(7):441-6. PubMed ID: 12368956
[TBL] [Abstract][Full Text] [Related]
23. Relationship between circulating cytokine levels and thyroid function following bone marrow transplantation.
Lee WY; Kang MI; Oh KW; Oh ES; Baek KH; Lee KW; Kim SW; Kim DW; Min WS; Kim CC
Bone Marrow Transplant; 2004 Jan; 33(1):93-8. PubMed ID: 14704661
[TBL] [Abstract][Full Text] [Related]
24. [Serum levels of solubule tumor necrosis factor (TNF) receptors in patients with pulmonary tuberculosis].
Kawaguchi H; Ina Y; Ito S; Sato S; Sugiura Y; Tomita H; Ogisu N; Takada K; Yamamoto M; Morishita M; Yoshikawa K
Kekkaku; 1996 Mar; 71(3):259-65. PubMed ID: 8901228
[TBL] [Abstract][Full Text] [Related]
25. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
[TBL] [Abstract][Full Text] [Related]
26. Immunological status of septic and trauma patients. I. High tumor necrosis factor alpha serum levels in septic and trauma patients are not responsible for increased mortality; a prognostic value of serum interleukin 6.
Adamik B; Zimecki M; Właszczyk A; Kübler A
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):169-75. PubMed ID: 9597083
[TBL] [Abstract][Full Text] [Related]
27. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide formation as predictive parameter for acute graft-versus-host disease after human allogeneic bone marrow transplantation.
Weiss G; Schwaighofer H; Herold M; Nachbaur D; Wachter H; Niederwieser D; Werner ER
Transplantation; 1995 Dec; 60(11):1239-44. PubMed ID: 8525517
[TBL] [Abstract][Full Text] [Related]
29. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
[TBL] [Abstract][Full Text] [Related]
30. Serum concentrations of interleukin-1 alpha, interleukin-6 and tumor necrosis factor-alpha in neonatal sepsis and meningitis.
Fida NM; Al-Mughales JA; Fadelallah MF
Saudi Med J; 2006 Oct; 27(10):1508-14. PubMed ID: 17013473
[TBL] [Abstract][Full Text] [Related]
31. Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.
Uberti JP; Ayash L; Ratanatharathorn V; Silver S; Reynolds C; Becker M; Reddy P; Cooke KR; Yanik G; Whitfield J; Jones D; Hutchinson R; Braun T; Ferrara JL; Levine JE
Biol Blood Marrow Transplant; 2005 Sep; 11(9):680-7. PubMed ID: 16125638
[TBL] [Abstract][Full Text] [Related]
32. Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes.
Castoldi G; Galimberti S; Riva C; Papagna R; Querci F; Casati M; Zerbini G; Caccianiga G; Ferrarese C; Baldoni M; Valsecchi MG; Stella A
Clin Sci (Lond); 2007 Jul; 113(2):103-8. PubMed ID: 17362204
[TBL] [Abstract][Full Text] [Related]
33. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
Nagaki M; Iwai H; Naiki T; Ohnishi H; Muto Y; Moriwaki H
J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
[TBL] [Abstract][Full Text] [Related]
34. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related?
Sebeková K; Podracká L; Heidland A; Schinzel R
Clin Nephrol; 2001 Dec; 56(6):S21-6. PubMed ID: 11770807
[TBL] [Abstract][Full Text] [Related]
35. Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation.
Nagler A; Bishara A; Brautbar C; Barak V
Cytokines Cell Mol Ther; 1998 Sep; 4(3):161-7. PubMed ID: 9825841
[TBL] [Abstract][Full Text] [Related]
36. Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activity.
D'Auria L; Mussi A; Bonifati C; Mastroianni A; Giacalone B; Ameglio F
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):11-5. PubMed ID: 10188143
[TBL] [Abstract][Full Text] [Related]
37. Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation.
Lee WY; Baek KH; Rhee EJ; Tae HJ; Oh KW; Kang MI; Lee KW; Kim SW; Kim CC; Oh ES
Bone Marrow Transplant; 2004 Jul; 34(1):89-94. PubMed ID: 15170175
[TBL] [Abstract][Full Text] [Related]
38. Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease.
Miyamoto T; Akashi K; Hayashi S; Gondo H; Murakawa M; Tanimoto K; Harada M; Niho Y
Bone Marrow Transplant; 1996 Feb; 17(2):185-90. PubMed ID: 8640164
[TBL] [Abstract][Full Text] [Related]
39. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
Toren A; Barak V; Novick D; Nagler A
Cytokines Cell Mol Ther; 1997 Sep; 3(3):153-8. PubMed ID: 9426973
[TBL] [Abstract][Full Text] [Related]
40. Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse.
Min CK; Kim SY; Eom KS; Kim YJ; Kim HJ; Lee S; Kim DW; Lee JW; Min WS; Kim CC
Bone Marrow Transplant; 2006 Mar; 37(5):493-8. PubMed ID: 16435015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
